Approaches to Dose Finding in Neonates, Illustrating the Variability between Neonatal Drug Development Programs

Approaches to Dose Finding in Neonates, Illustrating the Variability between Neonatal Drug Development Programs

Drug dosing in neonates should be based on integrated knowledge concerning the disease to be treated, the physiological characteristics of the neonate, and the pharmacokinetics (PK) and pharmacodynamics (PD) of a given drug. It is critically important that all sources of information be leveraged to...

Full description

Bibliographic Details
Main Authors: John N. Van den Anker, Susan McCune, Pieter Annaert, Gerri R. Baer, Yeruk Mulugeta, Ramy Abdelrahman, Kunyi Wu, Kevin M. Krudys, Jeffrey Fisher, William Slikker, Connie Chen, Gilbert J. Burckart, Karel Allegaert
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Pharmaceutics
Subjects:
drug development
newborn
neonatal clinical pharmacology
dose finding
pediatric drug delivery
Online Access:https://www.mdpi.com/1999-4923/12/7/685

Internet

https://www.mdpi.com/1999-4923/12/7/685

Similar Items